炎症生物标志物在预测胃癌预后中的作用
The Role of Inflammatory Biomarkers in Predicting the Prognosis of Gastric Cancer
摘要: 目的：本综述的目的是系统评估炎症生物标志物在预测胃癌预后中的作用。通过综合分析现有的研究文献，我们将总结LMR、NLR、PLR和RDW等炎症生物标志物在胃癌预后评估中的预测能力和机制解释。此外，我们还将讨论这些生物标志物在胃癌预后中的临床应用前景和潜在局限性。本综述将按照以下结构展开：首先，我们将回顾胃癌的全球流行病学数据和趋势，以及胃癌的发病率和死亡率。接下来，我们将探讨胃癌的分子亚型和临床表现。然后，我们将详细讨论胃癌预后的重要性和挑战，以及炎症在胃癌发展和预后中的作用。最后，我们将总结炎症生物标志物在预测胃癌预后中的作用，并讨论其临床应用的前景和限制。通过这个综述，我们旨在为胃癌预后评估提供全面的综合视角，为临床实践和进一步研究提供有价值的参考。结论：外周血NLR、PLR、LMR、RDW与胃癌患者预后有一定关系，对胃癌预后具有一定的预测价值。
Abstract: The aim of the review was to systematically assess the role of inflammatory biomarkers in predicting the prognosis of gastric cancer. By comprehensively analyzing the existing research literature, we will summarize the predictive power and mechanistic explanations of inflammatory biomarkers such as LMR, NLR, PLR, and RDW in the prognostic assessment of gastric cancer. In addition, we will discuss the clinical application prospects and potential limitations of these biomarkers in the prognosis of gastric cancer. This review will be structured as follows: First, we will review the global epidemiological data and trends of gastric cancer, as well as the incidence and mortality of gastric cancer. Next, we will explore the molecular subtypes and clinical manifestations of gastric cancer. Then, we will discuss in detail the importance and challenges of gastric cancer prognosis, as well as the role of inflammation in gastric cancer development and prognosis. Finally, we will review the role of inflammatory biomarkers in predicting the prognosis of gastric cancer and discuss the prospects and limitations of their clinical application. Through this review, we aim to provide a comprehensive perspective for the prognosis evaluation of gastric cancer, and provide a valuable reference for clinical practice and further research. Conclusions: Peripheral blood NLR, PLR, LMR and RDW have a certain relationship with the prognosis of gastric cancer patients, and have certain predictive value for the prognosis of gastric cancer.
文章引用：刘娜. 炎症生物标志物在预测胃癌预后中的作用[J]. 临床医学进展, 2023, 13(12): 19890-19898. https://doi.org/10.12677/ACM.2023.13122802

参考文献

[1] 姜海波. 208例青年胃癌患者临床流行病学特征及预后因素研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2014.
[2] 孙智沉, 刘宝瑞. 胃癌分子分型与个体化免疫治疗[J]. 中国肿瘤生物治疗杂志, 2018, 25(11): 1094-1098.
[3] 庞丽俊, 戴一龙, 王强. 中性粒细胞-淋巴细胞比值对胃癌预后影响的评估价值[J]. 青岛医药卫生, 2020, 52(6): 463-465.
[4] Sica, A., Allavena, P. and Mantovani, A. (2008) Cancer Related Inflammation: The Macrophage Connec-tion. Cancer Letters, 267, 204-215. [Google Scholar] [CrossRef] [PubMed]
[5] Liu, Y.T. and Sun, Z.J. (2021) Turning Cold Tumors into Hot Tumors by Improving T-Cell Infiltration. Theranostics, 11, 5365-5386. [Google Scholar] [CrossRef] [PubMed]
[6] Duan, Q., Zhang, H., Zheng, J. and Zhang, L.J. (2020) Turning Cold into Hot: Firing up the Tumor Microenvironment. Trends in Cancer, 6, 605-618. [Google Scholar] [CrossRef] [PubMed]
[7] 刘贤明, 彭丽丽, 任燕燕, 等. HER2阴性晚期胃癌患者外周血LMR、SII与PIV对生存结局的预测价值及预后影响因素研究[J]. 临床误诊误治, 2022, 35(11): 47-53.
[8] Russo, A., Russano, M., Franchina, T., et al. (2020) Neutrophil-to-Lymphocyte Ratio (NLR), Plate-let-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study. Advances in Therapy, 37, 1145-1155. [Google Scholar] [CrossRef] [PubMed]
[9] 林林琳, 李娜, 吴丽娜, 等. 外周血NLR、MLR、SII在甲状腺髓样癌中的应用价值[J]. 现代肿瘤医学, 2022, 30(10): 1753-1757.
[10] 赵冉, 施瑞华. 外周血NLR、PLR对胃肠胰神经内分泌肿瘤的诊断价值[J]. 肿瘤防治研究, 2019, 46(8): 724-728.
[11] 郭梁, 刘海鹏, 陈康, 等. 外周血NLR和PLR对胃癌预后评估的研究进展[J]. 医学综述, 2021, 27(4): 702-706.
[12] 王观星, 褚衍六. 胃癌术后预后评分系统研究进展[J]. 现代消化及介入诊疗, 2023, 28(5): 662-667.
[13] Chen, J., Hong, D., Zhai, Y. and Shen, P. (2015) Meta-Analysis of Associations between Neutrophil-to-Lymphocyte Ratio and Prognosis of Gastric Cancer. World Journal of Surgical Oncology, 13, Article No. 122. [Google Scholar] [CrossRef] [PubMed]
[14] 杨宁, 张伟, 钱峰, 等. 外周血PLR和NLR与Ⅲ、Ⅳ期胃癌患者化疗后预后相关性[J]. 分子诊断与治疗杂志, 2023, 15(1): 52-55.
[15] 余璠, 施德兵. 老年胃癌患者外周血NLR、RDW、Hcy水平与临床病理特征及预后的关系[J]. 中国老年学杂志, 2022, 42(18): 4421-4426.
[16] Dunn, G.P., Old, L.J. and Schreiber, R.D. (2004) The Immunobiology of Cancer Immunosurveillance and Immunoediting. Im-munity, 21, 137-148. [Google Scholar] [CrossRef] [PubMed]
[17] 赵阳, 程静. 手术前后中性粒细胞淋巴细胞比率变化对评估胃癌患者预后的临床价值[J]. 中国普外基础与临床杂志, 2020, 27(12): 1538-1542.
[18] Azimi, F., Scolyer, R.A., Rumcheva, P., et al. (2012) Tumor-Infiltrating Lymphocyte Grade Is an In-dependent Predictor of Sentinel Lymph Node Status and Survival in Patients with Cutaneous Melanoma. Journal of Clinical Oncology, 30, 2678-2683. [Google Scholar] [CrossRef] 
[19] 贺祺琛, 王科深, 王涛, 等. 淋巴细胞与单核细胞比值改变对局部进展期胃癌患者的预后价值: 单中心回顾性队列研究[J]. 中国普外基础与临床杂志, 2023, 30(5): 561-568.
[20] Jiang, R., Cai, X.Y., Yang, Z.H., et al. (2015) Elevated Peripheral Blood Lym-phocyte-to-Monocyte Ratio Predicts a Favorable Prognosis in the Patients with Metastatic Nasopharyngeal Carcinoma. Cancer Communications, 34, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[21] 程虹. 炎症指标与胃癌预后的相关性研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2020.
[22] 杜炜玮, 陈伟霞, 马纯政. 血清NLR、TK1与晚期胃癌患者健脾扶正汤治疗预后的相关性[J]. 分子诊断与治疗杂志, 2023, 15(1): 65-68. [Google Scholar] [CrossRef] 
[23] 罗俊峰, 胡军, 李包根, 等. 基于炎症反应评分系统构建胃癌患者预后的列线图预测模型[J]. 中国肿瘤生物治疗杂志, 2023, 30(10): 902-907.
[24] 梁思远, 韦传毅, 龙子雯, 等. 术前外周血血小板/淋巴细胞比值相关列线图模型预测胃癌患者术后无病生存期: 一项双中心回顾性研究[J]. 中国临床医学, 2023, 30(3): 391-396.
[25] Wu, J.L. (2022) Clinical Value of PLR, MLR, and NWR in Neoad-juvant Chemotherapy for Locally Advanced Gastric Cancer. Computational and Mathematical Methods in Medicine, 2022, Article ID: 8005975. [Google Scholar] [CrossRef] [PubMed]
[26] 陈健, 陈波, 王东, 等. 术前中性粒细胞淋巴细胞比、血小板淋巴细胞比和炎症营养指数对结直肠癌根治术患者预后的预测价值[J]. 肿瘤预防与治疗, 2022, 35(6): 514-519.
[27] 张涛. 复发转移性胃癌临床病理特征及预后的相关因素分析[D]: [硕士学位论文]. 广州: 广州中医药大学, 2022.[CrossRef] 
[28] Saito, T., Kurokawa, Y., Miyazaki, Y., et al. (2015) Which Is a More Reliable Indicator of Survival after Gastric Cancer Surgery: Postoperative Complication Occurrence or C-Reactive Protein Elevation. Journal of Surgical Oncology, 112, 894-899. [Google Scholar] [CrossRef] [PubMed]
[29] 牟阳阳, 任国成, 邢立莹. 红细胞分布宽度在心血管疾病中的研究现状[J]. 中西医结合心血管病电子杂志, 2019, 7(7): 194-195.
[30] Murakami, Y., Saito, H., Kono, Y., et al. (2018) Combined Analysis of the Preoperative and Post-operative Prognostic Nutritional Index Offers a Precise Predictor of the Prognosis of Patients with Gastric Cancer. Sur-gery Today, 48, 395-403. [Google Scholar] [CrossRef] [PubMed]
[31] 王洋洋, 刘艳, 张新宇, 等. 胃癌患者手术前后红细胞分布宽度的差异及对预后的判断价值[J]. 新疆医科大学学报, 2021, 44(7): 821-826.
[32] 徐锋, 梁友方, 单才华, 等. 胃癌患者GPDA和RDW的临床意义探讨[J]. 山西医药杂志, 2006, 35(8): 756.

为你推荐